Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FemSuite is an innovative medical technology company based in Israel that focuses on developing advanced solutions for women's pelvic health. The company's primary focus is the treatment of pelvic organ prolapse (POP), a condition affecting millions of women worldwide. FemSuite has developed a proprietary, non-surgical, and discreet wearable device designed to provide mechanical support to the pelvic organs, offering an alternative to traditional pessaries and invasive surgery. The device is engineered for comfort and ease of use, aiming to restore quality of life and confidence to patients. Operating within the Alon Medtech Ventures incubator, FemSuite leverages clinical expertise and user-centric design to address significant unmet needs in the urogynecology market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FemSuite.